Tweet
Oncotarget. 2015 Dec 23. doi: 10.18632/oncotarget.6746. [Epub ahead of print]
Ineffectiveness of the 2014-2015 H3N2 influenza vaccine.
Mandelboim M1, Glatman-Freedman A2,3, Drori Y1, Sherbany H1, Pando R1, Sefty H2, Zadka H2, Shohat T2,4, Keller N5,6, Mendelson E1,4.
Author information
Abstract
The seasonal influenza vaccine is currently the most effective preventive modality against influenza infection. Nasopharyngeal samples of vaccinated and non-vaccinated patients presenting with Influenza-like-illness (ILI) were collected from over 20 outpatient clinics located in different geographic parts of Israel and were tested for the presence of influenza viruses (influenza A and influenza B). Here we show, that in the 2014-2015 season, the vaccine that included the A/Texas/50/2012 H3N2 virus was ineffective. Significant numbers of individuals vaccinated with the 2014-2015 vaccine, of all ages, were infected with influenza A (H3N2), manifesting similar symptoms as the non-vaccinated group. We further demonstrate that the Israeli circulating influenza A(H3N2) virus was different than that included in the 2014-2015 northern hemisphere vaccine, and that antibodies elicited by this vaccine were significantly less efficient in neutralizing influenza A(H3N2) infection.
KEYWORDS:
Immune response; Immunity; Immunology and Microbiology Section; influenza; vaccine
PMID: 26716420 [PubMed - as supplied by publisher] Free full text
Ineffectiveness of the 2014-2015 H3N2 influenza vaccine.
Mandelboim M1, Glatman-Freedman A2,3, Drori Y1, Sherbany H1, Pando R1, Sefty H2, Zadka H2, Shohat T2,4, Keller N5,6, Mendelson E1,4.
Author information
Abstract
The seasonal influenza vaccine is currently the most effective preventive modality against influenza infection. Nasopharyngeal samples of vaccinated and non-vaccinated patients presenting with Influenza-like-illness (ILI) were collected from over 20 outpatient clinics located in different geographic parts of Israel and were tested for the presence of influenza viruses (influenza A and influenza B). Here we show, that in the 2014-2015 season, the vaccine that included the A/Texas/50/2012 H3N2 virus was ineffective. Significant numbers of individuals vaccinated with the 2014-2015 vaccine, of all ages, were infected with influenza A (H3N2), manifesting similar symptoms as the non-vaccinated group. We further demonstrate that the Israeli circulating influenza A(H3N2) virus was different than that included in the 2014-2015 northern hemisphere vaccine, and that antibodies elicited by this vaccine were significantly less efficient in neutralizing influenza A(H3N2) infection.
KEYWORDS:
Immune response; Immunity; Immunology and Microbiology Section; influenza; vaccine
PMID: 26716420 [PubMed - as supplied by publisher] Free full text